Multiple myeloma (MM) treatment has changed tremendously, with significant improvement in patient out-comes. One group with a suboptimal benefit is patients with high-risk cytogenetics, as tested by ...

To determine the proportion of uveal melanoma patients who accept cytogenetic prognostication and to understand the reasons for their decision and the psychological impact of an adverse prognosis.

Cytogenetics is a field of study that deals with chromosomes and related abnormalities. Chromosome analysis is also known as karyotyping and involves the pairing of homologous chromosomes.

Genetic testing for chronic myeloid leukemia (CML) can tell doctors if someone has leukemia, what type they may have, and whether treatment is working. The tests look for atypical changes in certain ...

Recent published studies have demonstrated the incremental value of the use of cell-free DNA for noninvasive prenatal testing with 100% sensitivity for trisomies 21 and 18 and a specificity of ≥99.7% ...

SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (NAS: ILMN) today announced that it has acquired Cambridge, U.K.-based BlueGnome Ltd. for an undisclosed sum. BlueGnome, now a wholly owned subsidiary of ...

Dublin, July 02, 2021 (GLOBE NEWSWIRE) -- The "Genetic Testing Market 2020-2026" report has been added to ResearchAndMarkets.com's offering. The global genetic testing market is growing at a ...

RYE BROOK, NY--(Marketwired - Jul 17, 2014) - CBLPath, a Sonic Healthcare USA laboratory, is pleased to announce the launch of its new cytogenetics division and the appointment of Murty V. Vundavalli, ...

Westford, USA,, April 06, 2023 (GLOBE NEWSWIRE) -- The Molecular Cytogenetics market is experiencing significant growth and is projected to reach USD 5.39 billion by 2030, with a CAGR of 10.47% during ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Molecular Cytogenetics Market - Forecast to 2021" report to their offering. The molecular cytogenetics market is ...

The appraisal committee considered evidence submitted by Pfizer and a review of this submission by the evidence review group (ERG). See the committee papers for full details of the evidence. Acute ...